🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Bioinformatics

Benchmark revenue and EBITDA valuation multiples for public comps like Recursion Pharmaceuticals, Twist Bioscience, Takara Bio, Immuneering and Vazyme Biotech.

Bioinformatics

See analyst estimates and all valuation multiples for Bioinformatics
Company EV EV/LTM Revenue EV/LTM EBITDA
$2.1B 31.2x -3.9x
$1.5B 4.1x -12.8x
$1.2B 5.4x 62.3x
$735M 3.8x -3.6x
$707M 8.3x 9.9x
$535M 1.7x 10.9x
$328M 57.8x -3.7x
$277M 3.6x -3.7x
$214M 2.2x 13.3x
$113M n/a n/a
$91.1M n/a n/a
$72.4M 27.7x n/a
$8.9M n/a n/a
$8.1M n/a n/a

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Bioinformatics

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.